#Específica ER# Convocatoria ayudas Foundation for Prader-Willi Research (FPWR)

Convocatoria 2019 de innovación abierta de Asahi Kasei Pharma

Grants: The Foundation for Prader-Willi Research (FPWR), a nonprofit organization dedicated to supporting research to advance the understanding and treatment of Prader-Willi syndrome (PWS), announces the availability of funds to support innovative PWS research. FPWR is particularly interested in supporting projects that will lead to new treatments to alleviate the symptoms associated with PWS. Funding priorities include:

  • Genotype to phenotype: understanding PWS genetics / how loss of PWS-critical region genes leads to the phenotype
  • Neurobiology of hunger / feeding behavior in PWS
  • Neurobiology of cognitive deficits, maladaptive behavior and mental illness in PWS
  • Clinical care research: evaluation of existing drugs and interventions to improve health and quality of life in PWS
  • Therapeutics development for PWS- Genetic therapies; novel pharmaceuticals; drug repurposing for PWS.

A full description of FPWR's funding priorities can be found here. In addition to these funding priorities, FPWR is pleased to announce a special priority areas for the Spring 2019 grant cycle: Brain Imaging Studies in Individuals with PWS.

Funds: Applicants may request up to $100,000 USD in direct costs for the initial year of support, with the possibility of a second year of funding upon competitive renewal. For the Special Priority Areas (Brain Imaging), applicants may request up to $150,000 per year in direct costs for the initial year of support, with the possibility of a second year of funding upon competitive renewal. Indirect costs of up to 8% are allowed.

Deadline:

Letter of Intent Due Date: March 4th, 2019, 5pm EST

Full Proposal Due Date: May 6th, 2019, 5pm EST

More information and submission

https://www.fpwr.org/hubfs/FPWR-LOI-Instructions-1.pdf

Entidad Financiadora: Asahi Kasei Pharma

Plazo de Presentación: 06/05/2019

Volver al Listado